SenoRx, Inc. Announces Launch of Its VisiLoc MRI Visible Obturator At the Annual Meeting of the Radiological Society of North America (RSNA)

ALISO VIEJO, Calif., Nov. 26, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (NasdaqGM:SENO - News) today announced the launch of its VisiLoc(tm) MRI visible obturator, compatible with its EnCor(r) breast biopsy system, at the annual meeting of the Radiological Society of North America (RSNA) in Chicago. The product facilitates location of a lesion for breast biopsy under MRI image guidance.

MORE ON THIS TOPIC